Click here to submit Post PR News
You are here: Home » Archives for Dr. Reddy’s Laboratories
Posts tagged "Dr. Reddy’s Laboratories"

Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F

by Dr. Reddy's on Jun 18, 2018 Healthcare, Medical Device & Hospitals • Comments Closed •
Hyderabad, India, June 16, 2018 Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2018 was filed  →
Views : 977

Dr. Reddy’s Laboratories announces the launch of Raloxifene HCl Tablets, USP in the U.S. Market

by admin on Nov 15, 2016 Pharmaceuticals • Comments Closed • , ,
Hyderabad, India and Princeton, NJ, USA. 11 November 2016 – Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Raloxifene hydrochloride tablets in 60 mg, a therapeutic equivalent generic version of Evista® (raloxifene  →
Views : 1315

Categories

Recent Posts

Archives




Create Free Account

........................................................................
You can create a free account with us to gain access to just released news and press releases about leading companies from across the world. Your free account can provide you with the latest industry and corporate information to help you take quick business decisions. With your free account, you can be amongst the first ones to know of the latest happenings. So Signup now !!.

© 2024 PRNewsServices. All Rights Reserved.